{"id":"https://openalex.org/W2809082012","doi":"https://doi.org/10.1016/j.ejphar.2018.06.022","title":"Administration of a co-crystal of tramadol and celecoxib in a 1:1 molecular ratio produces synergistic antinociceptive effects in a postoperative pain model in rats","display_name":"Administration of a co-crystal of tramadol and celecoxib in a 1:1 molecular ratio produces synergistic antinociceptive effects in a postoperative pain model in rats","publication_year":2018,"publication_date":"2018-06-19","ids":{"openalex":"https://openalex.org/W2809082012","doi":"https://doi.org/10.1016/j.ejphar.2018.06.022","mag":"2809082012","pmid":"https://pubmed.ncbi.nlm.nih.gov/29932927"},"language":"en","primary_location":{"id":"doi:10.1016/j.ejphar.2018.06.022","doi":"https://doi.org/10.1016/j.ejphar.2018.06.022","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejphar.2018.06.022","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.ejphar.2018.06.022","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048779913","display_name":"Manuel Merlos","orcid":"https://orcid.org/0000-0002-8423-3033","observed_orcids":["https://orcid.org/0000-0002-8423-3033"]},"institutions":[{"id":"https://openalex.org/I4405281164","display_name":"Parc Cient\u00edfic de Barcelona","ror":"https://ror.org/03z3b5m17","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4405281164","https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Manuel Merlos","raw_affiliation_strings":["Drug Discovery and Preclinical Development, E\ufeffs\ufefft\ufeffe\ufeffv\ufeffe\ufeff \ufeffP\ufeffh\ufeffa\ufeffr\ufeffm\ufeffa\ufeffc\ufeffe\ufeffu\ufefft\ufeffi\ufeffc\ufeffa\ufeffl\ufeffs\ufeff,\ufeff S.A., Parc Cient\u00edfic de Barcelona, Baldiri Reixac 4-8, 08028 Barcelona, Spain. Electronic address: mmerlos@esteve.com","Drug Discovery and Preclinical Development, E\ufeffs\ufefft\ufeffe\ufeffv\ufeffe\ufeff \ufeffP\ufeffh\ufeffa\ufeffr\ufeffm\ufeffa\ufeffc\ufeffe\ufeffu\ufefft\ufeffi\ufeffc\ufeffa\ufeffl\ufeffs\ufeff,\ufeff S.A., Parc Cient\u00edfic de Barcelona, Baldiri Reixac 4-8, 08028 Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery and Preclinical Development, E\ufeffs\ufefft\ufeffe\ufeffv\ufeffe\ufeff \ufeffP\ufeffh\ufeffa\ufeffr\ufeffm\ufeffa\ufeffc\ufeffe\ufeffu\ufefft\ufeffi\ufeffc\ufeffa\ufeffl\ufeffs\ufeff,\ufeff S.A., Parc Cient\u00edfic de Barcelona, Baldiri Reixac 4-8, 08028 Barcelona, Spain. Electronic address: mmerlos@esteve.com","institution_ids":["https://openalex.org/I4405281164"]},{"raw_affiliation_string":"Drug Discovery and Preclinical Development, E\ufeffs\ufefft\ufeffe\ufeffv\ufeffe\ufeff \ufeffP\ufeffh\ufeffa\ufeffr\ufeffm\ufeffa\ufeffc\ufeffe\ufeffu\ufefft\ufeffi\ufeffc\ufeffa\ufeffl\ufeffs\ufeff,\ufeff S.A., Parc Cient\u00edfic de Barcelona, Baldiri Reixac 4-8, 08028 Barcelona, Spain","institution_ids":["https://openalex.org/I4405281164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041539830","display_name":"Enrique F. Portillo-Salido","orcid":"https://orcid.org/0000-0002-4585-3715","observed_orcids":["https://orcid.org/0000-0002-4585-3715"]},"institutions":[{"id":"https://openalex.org/I4405281164","display_name":"Parc Cient\u00edfic de Barcelona","ror":"https://ror.org/03z3b5m17","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4405281164","https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Enrique Portillo-Salido","raw_affiliation_strings":["Drug Discovery and Preclinical Development, E\ufeffs\ufefft\ufeffe\ufeffv\ufeffe\ufeff \ufeffP\ufeffh\ufeffa\ufeffr\ufeffm\ufeffa\ufeffc\ufeffe\ufeffu\ufefft\ufeffi\ufeffc\ufeffa\ufeffl\ufeffs\ufeff,\ufeff S.A., Parc Cient\u00edfic de Barcelona, Baldiri Reixac 4-8, 08028 Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery and Preclinical Development, E\ufeffs\ufefft\ufeffe\ufeffv\ufeffe\ufeff \ufeffP\ufeffh\ufeffa\ufeffr\ufeffm\ufeffa\ufeffc\ufeffe\ufeffu\ufefft\ufeffi\ufeffc\ufeffa\ufeffl\ufeffs\ufeff,\ufeff S.A., Parc Cient\u00edfic de Barcelona, Baldiri Reixac 4-8, 08028 Barcelona, Spain","institution_ids":["https://openalex.org/I4405281164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011445358","display_name":"Alex Brenchat","orcid":"https://orcid.org/0000-0002-9284-8345","observed_orcids":["https://orcid.org/0000-0002-9284-8345"]},"institutions":[{"id":"https://openalex.org/I4405281164","display_name":"Parc Cient\u00edfic de Barcelona","ror":"https://ror.org/03z3b5m17","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4405281164","https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Alex Brenchat","raw_affiliation_strings":["Drug Discovery and Preclinical Development, E\ufeffs\ufefft\ufeffe\ufeffv\ufeffe\ufeff \ufeffP\ufeffh\ufeffa\ufeffr\ufeffm\ufeffa\ufeffc\ufeffe\ufeffu\ufefft\ufeffi\ufeffc\ufeffa\ufeffl\ufeffs\ufeff,\ufeff S.A., Parc Cient\u00edfic de Barcelona, Baldiri Reixac 4-8, 08028 Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery and Preclinical Development, E\ufeffs\ufefft\ufeffe\ufeffv\ufeffe\ufeff \ufeffP\ufeffh\ufeffa\ufeffr\ufeffm\ufeffa\ufeffc\ufeffe\ufeffu\ufefft\ufeffi\ufeffc\ufeffa\ufeffl\ufeffs\ufeff,\ufeff S.A., Parc Cient\u00edfic de Barcelona, Baldiri Reixac 4-8, 08028 Barcelona, Spain","institution_ids":["https://openalex.org/I4405281164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051165587","display_name":"Bertrand Aubel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405281164","display_name":"Parc Cient\u00edfic de Barcelona","ror":"https://ror.org/03z3b5m17","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4405281164","https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Bertrand Aubel","raw_affiliation_strings":["Drug Discovery and Preclinical Development, E\ufeffs\ufefft\ufeffe\ufeffv\ufeffe\ufeff \ufeffP\ufeffh\ufeffa\ufeffr\ufeffm\ufeffa\ufeffc\ufeffe\ufeffu\ufefft\ufeffi\ufeffc\ufeffa\ufeffl\ufeffs\ufeff,\ufeff S.A., Parc Cient\u00edfic de Barcelona, Baldiri Reixac 4-8, 08028 Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery and Preclinical Development, E\ufeffs\ufefft\ufeffe\ufeffv\ufeffe\ufeff \ufeffP\ufeffh\ufeffa\ufeffr\ufeffm\ufeffa\ufeffc\ufeffe\ufeffu\ufefft\ufeffi\ufeffc\ufeffa\ufeffl\ufeffs\ufeff,\ufeff S.A., Parc Cient\u00edfic de Barcelona, Baldiri Reixac 4-8, 08028 Barcelona, Spain","institution_ids":["https://openalex.org/I4405281164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041574268","display_name":"Jordi Buxens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405281164","display_name":"Parc Cient\u00edfic de Barcelona","ror":"https://ror.org/03z3b5m17","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4405281164","https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jordi Buxens","raw_affiliation_strings":["Drug Discovery and Preclinical Development, E\ufeffs\ufefft\ufeffe\ufeffv\ufeffe\ufeff \ufeffP\ufeffh\ufeffa\ufeffr\ufeffm\ufeffa\ufeffc\ufeffe\ufeffu\ufefft\ufeffi\ufeffc\ufeffa\ufeffl\ufeffs\ufeff,\ufeff S.A., Parc Cient\u00edfic de Barcelona, Baldiri Reixac 4-8, 08028 Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery and Preclinical Development, E\ufeffs\ufefft\ufeffe\ufeffv\ufeffe\ufeff \ufeffP\ufeffh\ufeffa\ufeffr\ufeffm\ufeffa\ufeffc\ufeffe\ufeffu\ufefft\ufeffi\ufeffc\ufeffa\ufeffl\ufeffs\ufeff,\ufeff S.A., Parc Cient\u00edfic de Barcelona, Baldiri Reixac 4-8, 08028 Barcelona, Spain","institution_ids":["https://openalex.org/I4405281164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009537199","display_name":"Angels Fisas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405281164","display_name":"Parc Cient\u00edfic de Barcelona","ror":"https://ror.org/03z3b5m17","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4405281164","https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Angels Fisas","raw_affiliation_strings":["Drug Discovery and Preclinical Development, E\ufeffs\ufefft\ufeffe\ufeffv\ufeffe\ufeff \ufeffP\ufeffh\ufeffa\ufeffr\ufeffm\ufeffa\ufeffc\ufeffe\ufeffu\ufefft\ufeffi\ufeffc\ufeffa\ufeffl\ufeffs\ufeff,\ufeff S.A., Parc Cient\u00edfic de Barcelona, Baldiri Reixac 4-8, 08028 Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery and Preclinical Development, E\ufeffs\ufefft\ufeffe\ufeffv\ufeffe\ufeff \ufeffP\ufeffh\ufeffa\ufeffr\ufeffm\ufeffa\ufeffc\ufeffe\ufeffu\ufefft\ufeffi\ufeffc\ufeffa\ufeffl\ufeffs\ufeff,\ufeff S.A., Parc Cient\u00edfic de Barcelona, Baldiri Reixac 4-8, 08028 Barcelona, Spain","institution_ids":["https://openalex.org/I4405281164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091728921","display_name":"Xavier Codony","orcid":"https://orcid.org/0000-0002-8921-6902","observed_orcids":["https://orcid.org/0000-0002-8921-6902"]},"institutions":[{"id":"https://openalex.org/I4405281164","display_name":"Parc Cient\u00edfic de Barcelona","ror":"https://ror.org/03z3b5m17","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4405281164","https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Xavier Codony","raw_affiliation_strings":["Drug Discovery and Preclinical Development, E\ufeffs\ufefft\ufeffe\ufeffv\ufeffe\ufeff \ufeffP\ufeffh\ufeffa\ufeffr\ufeffm\ufeffa\ufeffc\ufeffe\ufeffu\ufefft\ufeffi\ufeffc\ufeffa\ufeffl\ufeffs\ufeff,\ufeff S.A., Parc Cient\u00edfic de Barcelona, Baldiri Reixac 4-8, 08028 Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery and Preclinical Development, E\ufeffs\ufefft\ufeffe\ufeffv\ufeffe\ufeff \ufeffP\ufeffh\ufeffa\ufeffr\ufeffm\ufeffa\ufeffc\ufeffe\ufeffu\ufefft\ufeffi\ufeffc\ufeffa\ufeffl\ufeffs\ufeff,\ufeff S.A., Parc Cient\u00edfic de Barcelona, Baldiri Reixac 4-8, 08028 Barcelona, Spain","institution_ids":["https://openalex.org/I4405281164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058061813","display_name":"Luz I. Romero","orcid":"https://orcid.org/0000-0002-4148-1889","observed_orcids":["https://orcid.org/0000-0002-4148-1889"]},"institutions":[{"id":"https://openalex.org/I4405281164","display_name":"Parc Cient\u00edfic de Barcelona","ror":"https://ror.org/03z3b5m17","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4405281164","https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Luz Romero","raw_affiliation_strings":["Drug Discovery and Preclinical Development, E\ufeffs\ufefft\ufeffe\ufeffv\ufeffe\ufeff \ufeffP\ufeffh\ufeffa\ufeffr\ufeffm\ufeffa\ufeffc\ufeffe\ufeffu\ufefft\ufeffi\ufeffc\ufeffa\ufeffl\ufeffs\ufeff,\ufeff S.A., Parc Cient\u00edfic de Barcelona, Baldiri Reixac 4-8, 08028 Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery and Preclinical Development, E\ufeffs\ufefft\ufeffe\ufeffv\ufeffe\ufeff \ufeffP\ufeffh\ufeffa\ufeffr\ufeffm\ufeffa\ufeffc\ufeffe\ufeffu\ufefft\ufeffi\ufeffc\ufeffa\ufeffl\ufeffs\ufeff,\ufeff S.A., Parc Cient\u00edfic de Barcelona, Baldiri Reixac 4-8, 08028 Barcelona, Spain","institution_ids":["https://openalex.org/I4405281164"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026686227","display_name":"Daniel Zamanillo","orcid":"https://orcid.org/0000-0002-1032-6093","observed_orcids":["https://orcid.org/0000-0002-1032-6093"]},"institutions":[{"id":"https://openalex.org/I4405281164","display_name":"Parc Cient\u00edfic de Barcelona","ror":"https://ror.org/03z3b5m17","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4405281164","https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Daniel Zamanillo","raw_affiliation_strings":["Drug Discovery and Preclinical Development, E\ufeffs\ufefft\ufeffe\ufeffv\ufeffe\ufeff \ufeffP\ufeffh\ufeffa\ufeffr\ufeffm\ufeffa\ufeffc\ufeffe\ufeffu\ufefft\ufeffi\ufeffc\ufeffa\ufeffl\ufeffs\ufeff,\ufeff S.A., Parc Cient\u00edfic de Barcelona, Baldiri Reixac 4-8, 08028 Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery and Preclinical Development, E\ufeffs\ufefft\ufeffe\ufeffv\ufeffe\ufeff \ufeffP\ufeffh\ufeffa\ufeffr\ufeffm\ufeffa\ufeffc\ufeffe\ufeffu\ufefft\ufeffi\ufeffc\ufeffa\ufeffl\ufeffs\ufeff,\ufeff S.A., Parc Cient\u00edfic de Barcelona, Baldiri Reixac 4-8, 08028 Barcelona, Spain","institution_ids":["https://openalex.org/I4405281164"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024404946","display_name":"Jos\u00e9 Miguel Vela","orcid":"https://orcid.org/0000-0002-6809-1477","observed_orcids":["https://orcid.org/0000-0002-6809-1477"]},"institutions":[{"id":"https://openalex.org/I4405281164","display_name":"Parc Cient\u00edfic de Barcelona","ror":"https://ror.org/03z3b5m17","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4405281164","https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jos\u00e9 Miguel Vela","raw_affiliation_strings":["Drug Discovery and Preclinical Development, E\ufeffs\ufefft\ufeffe\ufeffv\ufeffe\ufeff \ufeffP\ufeffh\ufeffa\ufeffr\ufeffm\ufeffa\ufeffc\ufeffe\ufeffu\ufefft\ufeffi\ufeffc\ufeffa\ufeffl\ufeffs\ufeff,\ufeff S.A., Parc Cient\u00edfic de Barcelona, Baldiri Reixac 4-8, 08028 Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Discovery and Preclinical Development, E\ufeffs\ufefft\ufeffe\ufeffv\ufeffe\ufeff \ufeffP\ufeffh\ufeffa\ufeffr\ufeffm\ufeffa\ufeffc\ufeffe\ufeffu\ufefft\ufeffi\ufeffc\ufeffa\ufeffl\ufeffs\ufeff,\ufeff S.A., Parc Cient\u00edfic de Barcelona, Baldiri Reixac 4-8, 08028 Barcelona, Spain","institution_ids":["https://openalex.org/I4405281164"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5048779913"],"corresponding_institution_ids":["https://openalex.org/I4405281164"],"apc_list":{"value":3230,"currency":"USD","value_usd":3230},"apc_paid":{"value":3230,"currency":"USD","value_usd":3230},"fwci":2.1846,"has_fulltext":false,"cited_by_count":33,"citation_normalized_percentile":{"value":0.86057734,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"833","issue":null,"first_page":"370","last_page":"378"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.3970000147819519,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.3970000147819519,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10189","display_name":"Anesthesia and Pain Management","score":0.38670000433921814,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.0723000019788742,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tramadol","display_name":"tramadol","score":0.9610000252723694},{"id":"https://openalex.org/keywords/celecoxib","display_name":"celecoxib","score":1.0},{"id":"https://openalex.org/keywords/cocrystals","display_name":"cocrystals","score":0.871999979019165},{"id":"https://openalex.org/keywords/analgesic-synergy","display_name":"synergistic analgesia","score":0.7260000109672546},{"id":"https://openalex.org/keywords/antinociception","display_name":"antinociception","score":0.8360000252723694},{"id":"https://openalex.org/keywords/postoperative-pain","display_name":"postoperative pain","score":0.9990000128746033},{"id":"https://openalex.org/keywords/acute-pain","display_name":"acute pain","score":0.492000013589859},{"id":"https://openalex.org/keywords/opioid-sparing-analgesia","display_name":"opioid-sparing analgesia","score":0.7979999780654907},{"id":"https://openalex.org/keywords/cox-2-inhibition","display_name":"COX-2 inhibition","score":0.7089999914169312}],"concepts":[{"id":"https://openalex.org/C2779777798","wikidata":"https://www.wikidata.org/wiki/Q407592","display_name":"Tramadol","level":3,"score":0.913000226020813},{"id":"https://openalex.org/C2776467144","wikidata":"https://www.wikidata.org/wiki/Q408801","display_name":"Celecoxib","level":2,"score":0.8030632734298706},{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.7182924747467041},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6727935075759888},{"id":"https://openalex.org/C2776029756","wikidata":"https://www.wikidata.org/wiki/Q407535","display_name":"Oxycodone","level":4,"score":0.5903982520103455},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5821375250816345},{"id":"https://openalex.org/C2778722691","wikidata":"https://www.wikidata.org/wiki/Q57055","display_name":"Acetaminophen","level":2,"score":0.578557014465332},{"id":"https://openalex.org/C42533223","wikidata":"https://www.wikidata.org/wiki/Q1378064","display_name":"ED50","level":3,"score":0.5614587664604187},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.5467341542243958},{"id":"https://openalex.org/C2777866328","wikidata":"https://www.wikidata.org/wiki/Q174723","display_name":"Codeine","level":3,"score":0.518233060836792},{"id":"https://openalex.org/C15490471","wikidata":"https://www.wikidata.org/wiki/Q2734305","display_name":"Nociception","level":3,"score":0.4764312207698822},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.46768122911453247},{"id":"https://openalex.org/C2780820201","wikidata":"https://www.wikidata.org/wiki/Q173235","display_name":"Analgesic","level":2,"score":0.4638051986694336},{"id":"https://openalex.org/C2779245659","wikidata":"https://www.wikidata.org/wiki/Q1633866","display_name":"Hyperalgesia","level":4,"score":0.44596847891807556},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1342933475971222},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068579","descriptor_name":"Celecoxib","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000082","descriptor_name":"Acetaminophen","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006930","descriptor_name":"Hyperalgesia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009020","descriptor_name":"Morphine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010098","descriptor_name":"Oxycodone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010147","descriptor_name":"Pain Measurement","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010149","descriptor_name":"Postoperative Pain","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010149","descriptor_name":"Postoperative Pain","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D014147","descriptor_name":"Tramadol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D059408","descriptor_name":"Pain Management","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.ejphar.2018.06.022","doi":"https://doi.org/10.1016/j.ejphar.2018.06.022","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejphar.2018.06.022","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:29932927","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29932927","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of pharmacology","raw_type":"Comparative Study"}],"best_oa_location":{"id":"doi:10.1016/j.ejphar.2018.06.022","doi":"https://doi.org/10.1016/j.ejphar.2018.06.022","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejphar.2018.06.022","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320335974","display_name":"Mundipharma Research GmbH and Co.KG","ror":null}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":59,"referenced_works":["https://openalex.org/W110568474","https://openalex.org/W1536502087","https://openalex.org/W1675900714","https://openalex.org/W1919235808","https://openalex.org/W1968164845","https://openalex.org/W1968547286","https://openalex.org/W1969186319","https://openalex.org/W1979528889","https://openalex.org/W1979722597","https://openalex.org/W1992255438","https://openalex.org/W1993188399","https://openalex.org/W1994593971","https://openalex.org/W1995008519","https://openalex.org/W1995739533","https://openalex.org/W1996829062","https://openalex.org/W2004489626","https://openalex.org/W2004518367","https://openalex.org/W2006194553","https://openalex.org/W2007440728","https://openalex.org/W2014007136","https://openalex.org/W2018762794","https://openalex.org/W2018777427","https://openalex.org/W2036288371","https://openalex.org/W2040544575","https://openalex.org/W2049069390","https://openalex.org/W2060544849","https://openalex.org/W2062109461","https://openalex.org/W2065069000","https://openalex.org/W2066187627","https://openalex.org/W2070993468","https://openalex.org/W2072968157","https://openalex.org/W2079944456","https://openalex.org/W2081004887","https://openalex.org/W2082275407","https://openalex.org/W2087454739","https://openalex.org/W2094079527","https://openalex.org/W2103351070","https://openalex.org/W2106493551","https://openalex.org/W2115364368","https://openalex.org/W2123693245","https://openalex.org/W2123839799","https://openalex.org/W2124486392","https://openalex.org/W2126468989","https://openalex.org/W2127023036","https://openalex.org/W2129725155","https://openalex.org/W2132593672","https://openalex.org/W2141258812","https://openalex.org/W2142488826","https://openalex.org/W2147808981","https://openalex.org/W2153612682","https://openalex.org/W2170823871","https://openalex.org/W2172201406","https://openalex.org/W2206860290","https://openalex.org/W2235570983","https://openalex.org/W2270927172","https://openalex.org/W2594837965","https://openalex.org/W2750323361","https://openalex.org/W2751977187","https://openalex.org/W4296816736"],"related_works":["https://openalex.org/W4390744478","https://openalex.org/W7154598134","https://openalex.org/W4402761924","https://openalex.org/W4399679141","https://openalex.org/W4390638196","https://openalex.org/W2804670096","https://openalex.org/W4410037021","https://openalex.org/W2943449234","https://openalex.org/W4281915814","https://openalex.org/W2370977621"],"abstract_inverted_index":{"supports":[0],"the":[1,7],"further":[2],"investigation":[3],"of":[4,10],"CTC":[5],"in":[6],"clinical":[8],"management":[9],"moderate-to-severe":[11],"acute":[12],"pain":[13],"as":[14],"an":[15],"alternative":[16],"to":[17],"strong":[18],"opioids.":[19]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":3},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-06-29T00:00:00"}